A detailed history of Shay Capital LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Shay Capital LLC holds 75,216 shares of QURE stock, worth $1.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
75,216
Previous 69,702 7.91%
Holding current value
$1.3 Million
Previous $312,000 18.59%
% of portfolio
0.06%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.78 - $10.12 $20,842 - $55,801
5,514 Added 7.91%
75,216 $370,000
Q2 2024

Aug 14, 2024

BUY
$4.39 - $5.43 $21,405 - $26,476
4,876 Added 7.52%
69,702 $312,000
Q1 2024

May 15, 2024

BUY
$4.82 - $6.93 $249,550 - $358,793
51,774 Added 396.67%
64,826 $337,000
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $73,482 - $107,940
13,052 New
13,052 $88,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $811M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.